Methods. DBA/1 mice were immunized against bovine type II collagen. Before the onset of arthritis, NIH/3T3 fibroblasts transfected with pMFG-IRAP were transplanted into the knee cavity. Normal NIH/3T3 cells served as controls. Paws were evaluated macroscopically for redness, swelling, and deformities during the course of arthritis. Swelling of the knee joints was measured by external gamma counting of 99mtechnetium accumula tion in the joint. Paws and knee joints were dissected and processed for histologic studies to evaluate inflam mation and cartilage destruction.
bated for 2 minutes in 0.2% Triton X-100 to permeabilize cell membranes. Endogenous peroxidase was blocked by incuba tion in 0.5% UUO-, in PBS. After a further wash in PBS, sections were incubated overnight with polyclonal rabbit anti-HuIL-lRa antibodies (Genzyme, Cambridge, MA) diluted 1:500 in 4% nonfat dry milk in PBS. Sections were washed and incubated for 1 hour with goat anti-rabbit biotinylated anti bodies (Vector, Burlingame, CA). Secondary antibodies were detected with an avidin-biotin-peroxidase complex (Vectastain ABC Kit; Vector). After washing again in PBS, perox idase activity was detected by 10-minute incubation in 0.5 mg/ml 3.3'-diaminobenzidine tetrahydrochloride (Sigma, St. Louis, MO) dissolved in 0.05M Tris HC1 buffer, pH 7.6, containing 0.02% H20 2. Finally, sections were counterstained with Mayer's hematoxylin and embedded in gelatin-glycerin.
Induction of zymosan-induced arthritis (ZIA) and treatment protocol. A homogeneous suspension of 30 mg A (Saccharomyces cerevisiae) dissolved in 1 ml endotoxin-free saline was obtained by boiling twice followed by sonic émulsification. Arthritis was induced by intraarticular injection of 180 /xg zymosan into the knee joint. HuIL-lRaproducing cells or 3T3 cells (2 X 105) were injected intraarticularly into the knee joint 2 days before induction of ZIA. Two days after induction of ZIA, knee joint inflammation was assessed by 'Wrntechnetium pertechnetate uptake, and proteo glycan (PG) synthesis was determined by in vitro 35S-sulfate incorporation in patellae.
Assessment of knee joint swelling. Joint swelling was quantified by 99mTc uptake as previously described (6) . Briefly, 10 ju-Ci WmTc in 0,2 ml saline was injected subcutaneously in the neck region, and mice were sedated by intraperitoneal injection of 4.5% chloral hydrate (0.1 ml/10 mg body weight). Accumulation of the isotope in the knee was determined after 30 minutes by external gamma counting.
Induction of CIA and treatment protocol. DBA/1 mice, age 9-10 weeks at the start of experiments, were immunized intradermally at the base of the tail with bovine type II collagen (100 fxg) emulsified in Freund's complete adjuvant (Difco, Detroit, MI). On day 21, the animals were boosted with an intraperitoneal injection of 100 /xg type II collagen. Gradual onset of arthritis normally starts approximately 4 weeks after immunization. In the first experiment, 10 mice that did not yet have any macroscopic signs of arthritis were selected at 32 days after the initial immunization. These mice received 2 X 105 HuIL-lRa-producing cells in the right knee and 2 X 105 normal NIH/3T3 cells in the left knee. In the second experi ment, we took mice before arthritis onset, 23 days after the initial immunization, and divided them either 2 X 105 normal 3T3 cells (n = 10), HuIL-l Ra cells (5 /xg/10 \s ; n a HuIL-lRa-= 9) in the = 10), or producing cell-line (2.1 /xg/10(' cells/24 hours; n right knee joint. Saline was injected into the left knee joint. CIA development in the first experiment was evaluated by assessment of knee swelling on day 4 and macroscopic scoring of the draining paws and histologic analysis on day 5. CIA development in the second experiment was assessed by mac roscopic scoring of the draining paws and histologic analysis of the knees on day 5.
Macroscopic scoring of CIA. Erythema and swelling of the paws were scored on a 0-2 scale, with a maximum score of 2 for each paw. Scoring was done by 2 independent observers, LOCAL HuIL-lRa GENE THERAPY IN MURINE CIA 895 and the mean scores from the 2 observers were used for analyses.
Assessment of PG synthesis. Patellae were dissected so as to minimize the amount of adjoining synovium, tendon, and muscle, and placed in 200 jtxl RPMI-HEPES medium (Life Technologies, Breda, The Netherlands) supplemented with entamicin (50 mg/liter), L-glutamine (2 mM), and 40 ju,Ci 35S-sulfate/2 ml. After a 3-hour incubation, patellae were fixed in 10% formalin, decalcified in formic acid (4%), punched out, and dissolved in 0.5 ml Lumasolve (Omnilab, Breda, The « m * Netherlands). The * * S content of each patella was measured by liquid scintillation counting and expressed as counts per minute.
To determine the in vitro potency of recombinant HuIL-IRa (rHuIL-IRa), patellae from normal C57B1/6 mice were isolated. PG synthesis was measured after incubation of the patellae with or without 1 ng/ml or 10 ng/ml recombinant murine IL -la (rMuIL-la) for 48 hours in medium supple mented with 0.5 /u-g/ml insulin-like growth factor in the pres ence of various amounts of rHuIL-IRa (generously provided by Amgen, Boulder, CO). After 48 hours, the 35S-sulfate content of the patellae was measured as described above. PG breakdown was measured by first prelabeling the patellae as described above, followed by a 48-hour incubation in medium in the presence of 10 ng/ml rM uIL-la and various concentra tions of rHuIL-IRa. The 35S-sulfate content of the patellae was again measured as described above. Data are shown as the percentage of 35S-sulfate incorporation in the right (experi mental) knee compared with the left (control) knee.
Histologic processing and analysis of knee joints. Knee joints were dissected, fixed, decalcified, dehydrated, and embedded in paraffin. Standard frontal sections of 7 ¡xm were prepared, stained with Safranin O, and counterstained with fast green. Cartilage depletion was visualized by diminished staining of the matrix and scored arbitrarily as 0 when normal or 1-3 according to the degree of depletion (loss of staining). Exudate was scored arbitrarily as 0 when no cells were present in the joint space or 1-3 according to the cell content of the joint space (predominantly polymorphonuclear cells).
For autoradiography, 35S-sulfate (50 /xCi per animal) was administered to the animals shortly (2 hours) before killing and knee and ankle joints prepared for histologic study. Sections were mounted on gelatin-coated slides, dipped in K5 emulsion (Ilford, Basildon, UK) and developed weeks (21).
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i » | m Statistical analysis. Data are expressed as the mean SD. Statistical analyses were performed using the 2-sample /-test for parametric data, and the Wilcoxon signed rank test for nonparametric data.
RESULTS

Potency of HuIL-IRa in blocking effects of IL-1 on patellae in vitro.
To determine the amount of rHuIL-lRa needed to completely block rMuIL-la, patellae from normal C57B1/6 mice were isolated and cultured with saline, 1 ng/ml rMuIL-la, or 10 ng/ml rMuIL-la, either alone or together with various concentrations of rHuIL-IRa (Table 1) . From these experiments, it was evident that in vitro, at least a 1,000-fold excess of 
rHuIL-IRa over rMuIL-la is needed to completely block the effects of rMuIL-la on PG synthesis and breakdown in patellar cartilage. In vivo application of HuIL-IRa by transplanta tion of HuIL-lRa-producing 3T3 cells to knee joints.
We examined, by immunohistochemistry, local produc tion of HuIL-IRa after transplantation of HuIL-lRaproducing 3T3 cells to C57B1/6 and DBA/1 mice. In C57B1/6 mice, HuIL-lRa-containing cells were retained in the knees for at least 7 days (Figure 1 ). No signs of inflammation (granulocyte influx) were observed, but a slight thickening of the synovial lining was seen, swelling as measured by t)t;m Tc uptake was negligible, and cartilage damage or PG depletion was not observed on histologic sections. Since the CIA experiments had to be performed in susceptible DBA/1 mice, we also in jected 3T3 cells or HuIL-lRa-producing cells into the knee joints of mice of this strain. In none of the animals was significant joint pathology noted on day 5, and local HuIL-IRa production was similar compared with the 2,10 pattern seen in shown), consistent with earlier observations that PG synthesis inhibition, but not synovial infiltration, is IL-1 dependent in this model (7) . (4,5,8 ). In the first experiment, 10 type II collagen-immunized mice without signs of arthritis on day 32 were selected. Cells producing HuIL-IRa were injected into the right knee joints, whereas 3T3 cells injected into the left knee joints served as controls. Knee joint swelling was measured by " mTc uptake 4 days after transplanta tion of the cells. The mean ± SD left/right ratio for the 10 mice was 1.72 ± 0.37. In only 1 mouse did both knees appear equally swollen; but in all other mice knee was swollen scopically normal. Thus, in 9 of 10 mice, after transplantation of the cells, knee joint sections were prepared for histologic study and autoradiography was performed to measure cartilage chondrocyte func-
3T3 = normal 3T3 cells; HuIL-IRa (1) producing 5 /¿g HuIL-lRa/106 cells/24 hours; saline knees from all 3 groups; HuIL-IRa (2) = /xg/HuIL-lRa/10f' cells/24 hours. See Table 1 for other definitions, t Exudate was scored arbitrarily as 0 when no cells were present in the joint space or 1-3 according to the cell content of the joint space (predominantly polymorphonuclear cells). $ PG loss of femur and patellar cartilage. Cartilage PG depletion was 0 when normal or 1-3 according to the degree of loss of
Effect of the transplanted HuIL-lRa-producing cells on CIA in the knee joint. Onset of murine CIA generally occurs approximately 4 -6 weeks after the first immunization and has been shown to be IL-1 dependent
incorpo ration in cartilage, whereas noninflamed knees had normal 35SQincorporation. Occurrence of marked cell influx and major tissue destruction was seen in 7 of 10 left knee joints transplanted with normal 3T3 cells, versus only 1 of 10 of the right knee joints transplanted with HuIL-lRa-producing cells. Affected knees had severe histologic scores (>2) for infiltrate, exudate, and PG loss, resembling classic CIA.
In a second experiment, mice were selected just before the onset of CIA, on day 23 after the initial immunization. In this experiment, 3T3 cells or 2 differ ent HuIL-lRa-producing clones were transplanted into knee joints. Five days later, knee joints were scored ular injection), 50% of the right and left knee joints Figure 5 ). The left, saline-injected knees from all 3 treatment groups were comparable with those from the untreated group, suggesting that HulL-IRa expression in the right knee had no effect on the contralateral saline-injected knee. Histologic examination showed marked protection of the knee joints transplanted with either of the HuIL-lRa-producing cell lines compared with the knee joints transplanted with normal 3T3 cells, with respect to exudate, infiltrate, and PG loss ( Table 2 ). The contralateral saline-injected knees from all 3 groups all developed CIA and had similar scores for infiltrate, exudate, and PG depletion of cartilage.
developed arthritis (Figure 5). Occurrence of arthritis was enhanced in the 3T3-transplanted knees (90%). In the HuIL-lRa-transplanted knees, occurrence of arthri tis was markedly decreased, to 10% (5 /mg HuIL-lRa/106 cells/24 hours) and 22% (2.1 /xg HuIL-lRa/106 cells/24 hours) (
Effect of HulL-IRa expression on draining and remote paws. Human IL-IRa expression in the knee seemed to also have a positive effect on the draining paws. To further assess this phenomenon, paws were macroscopically scored at the same time points as histo logic specimens were obtained from the knees. In the second experiment, 50% of the untreated group devel oped arthritis in the right and left paws ( Figure 6) . Expression was slightly enhanced in the draining paws from the 3T3-transplanted knees (70%). In contrast, in Figure 6 . Occurrence of arthritis in the paws of type II collagenimmunized mice transplanted with HuIL-lRa-producing 3T3 cells (second experiment). In the untreated group (n = 8), mice showed normal development of collagen-induced arthritis in the paws. In the other 3 groups, cells were transplanted into the right knee joint and saline was injected into the left knee joint. Values are the means. See Figure 5 for definitions. the draining paws from the HuIL-lRa-transplanted knees, the occurrence of arthritis was markedly de creased, to 10% (5 jag HuIL-lRa/106 cells/24 hours) and 11% (2.1 /xg HuIL-lRa/106 cells/24 hours) ( Figure 6) . The draining paws of the contralateral (knees injected with saline) from all 3 groups showed an arthritis incidence comparable with that found in the untreated group, demonstrating that HulL-IRa expres sion in the right knee had no effect on the contralateral paws. Occurrence of linkage between arthritis in the knee and paw of one leg was further analyzed. Either preferential expression in both ind (3T3 group) or dominant absence at both sites (the 2 HuIL- (Table 3) , whereas selective expression either in knee or in paw was rarely seen.
DISCUSSION
We used the ex vivo method of gene transfer as described by Bandara et al (15) to obtain local and sustained expression of HuIL-IRa in the knee. It was found that this approach prevented the onset of CIA not only in that knee, but also in the nearby, draining paw. Contralateral knee and paw joints were not protected. Control NIH/3T3 not expressing HuIL-IRa en hanced, rather than suppressed, the onset of arthritis.
Using immunohistochemistry methods, we have shown that the transduced into the knee cavity continue producing the HuIL-IRa protein for at least 7 days. Furthermore, transplantation of 2 X 105 HuIL-lRa-producing cells into the knee joint could completely block the effects of an intraarticular injection of 1 ng rMuIL-la on patellar PG synthesis. Since it is known from previous studies that the peak levels of IL-1 produced by the inflamed synovial tissue after onset of arthritis do not exceed the nanogram level, the selected HuIL-lRa-producing cells are sufficiently potent.
One concern about application of local gene therapy is a potential disturbing effect of the inflamma tory process on protein production and, for the ex vivo method in particular, the nonspecific effect of the trans planted cells on the inflammation process. To evaluate this we used the model of ZIA, in which we demon strated previously that the inhibition of chondrocyte PG synthesis could be completely prevented, but that the joint swelling was only marginally suppressed, with neu tralizing anti-IL-1 antibodies (7). In the present study we noted that local expression of HuIL-IRa in the knee during ZIA barely affected joint swelling (yi)mTc up take), consistent with IL-1 independence of cartilage PG synthesis was clearly i more, transplantation of NIH/3T3 cells ZIA-related joint mg or a inhibition. These observations demonstr that the cells do not influence ZIA and HuIL-IRa is produced during the inflammation. In comparison with our in vitro blocking studies (Table 1) 
, we can extrapo late that we must have achieved at least a 300-fold excess of HuIL-IRa above local murine IL-1 levels to explain the positive effect on PG This indirectly proves that the transplanted cells still produce consider able amounts of H uIL-IRa under conditions of inflammation.
In Due to the monarthritic nature of these experimental arthritis models, those investigators could not determine the of HuIL-IRa production in the on nearby and more remote joints. The polyarthritic nature of the CIA model allowed us to obtain such information. We observed that local HuIL-IRa production in the not only prevented onset of CIA in that knee, but of CIA in the draining paw, contralateral leg was seems to link with previous work (24), in which we that expression of collagen arthritis in a particu I a v can be by local cytokine-generating stimuli such as zymosan, and that high concomitant occur l in the draining paw but not in the remote joints. Furthermore, Staite et al (11) have shown that IL-1 administered in the knee augments a local inflammatory response of methylated bovine serum albumin at that site, but also affects the ipsilateral paw. These data suggesting cou pling of arthritic processes in nearby joints may indicate that gene therapy applied to a larger joint could exert protective effects in smaller joints of hands or feet.
It is debatable whether the ex vivo method is the ideal gene therapy technique. In at it is labor intensive, with local vectors or 4 C change during the transfer from to culture conditions and back. However, cell targeting is possible in vitro, and some of the adenoviral vectors show inflammatory properties and need further constructive cleaning. The present data provide good evidence for the possibilities of local expression of therapeutic pro teins for treatment of arthritis. We have shown that transplantation of cells producing HuIL-IRa to the knee cavity can protect articular cartilage against IL-1induced inhibition of PG synthesis and can prevent onset of CIA not only in the transplanted knees, but also in the draining paws. It is expected that better vectors will become available in the near future to optimize expres sion and targeting to relevant cells and tissues of the joint.
